Adhesives and related methods

Abstract

Cure in place pressure sensitive adhesive compositions are described that comprise one or more of a bodying component, a structural diluent, a radical diluent as well as additives such as crosslinkers, external catalysts, photoinitiators and stabilizers/process aids. The bodying component can be acrylic or non-acrylic.

What is claimed: 
     
       1. A cure in place liquid comprising:
 5-70 wt% of a bodying component comprising a non-acrylic base polymer having a Mw of 5,000 to 1,000,000, selected from the group consisting of polyolefins, polyvinyl aromatics, polyurethanes, polycarbonates, polyesters, polyethers, and combinations thereof; 
 0-40 wt% of at least one structural diluent; 
 30-95 wt% of at least one radical addition diluent; 
 0-10.0 wt% of a curative; 
 0-10 wt% photosensitizer; and 
 0-10 wt% stabilizer. 
 
     
     
       2. The cure in place liquid of  claim 1  wherein the curative is a photoinitiator. 
     
     
       3. The cure in place liquid of  claim 1  wherein the non-acrylic base polymer is a pre-polymerized non-acrylic backbone base polymer. 
     
     
       4. The cure in place liquid composition of  claim 3  wherein the pre-polymerized non-acrylic backbone base polymer does not contain any ethylenic unsaturation along the polymer chain. 
     
     
       5. A construction comprising:
 a substrate; and 
 the cure in place liquid of  claim 1  disposed on the substrate. 
 
     
     
       6. A cure in place liquid comprising:
 5-70 wt% of a bodying component comprising a pre-polymerized non-acrylic backbone base polymer having a molecular weight (Mw) of 5,000 to 1,000,000, selected from the group consisting of polyolefins, polyvinyl aromatics, polyurethanes, polycarbonates, polyesters, polyethers, and combinations thereof; 
 0-40 wt% of at least one structural diluent; 
 30-95 wt% of at least one radical addition diluent; 
 0-10.0 wt% of a curative; 
 0-10 wt% photosensitizer; and 
 0-10 wt% stabilizer, 
 wherein the pre-polymerized non-acrylic backbone base polymer does not contain any ethylenic unsaturation along the polymer chain. 
 
     
     
       7. The cure in place liquid of  claim 1  wherein the radical addition diluent is selected from the group consisting of epoxy acrylate monomer (ACE™ hydroxyl acrylate), isostearyl acrylate, heptadecyl acrylate, dicyclopentadiene acrylate, 3-ethyl-3-(methyl acrylate) oxetane (OXE-10), 3-ethyl-3-(methyl methacrylate) oxetane (OXE-30), 3,4-epoxycyclohexyl methyl methacrylate (S-100), acrylic macromer having a molecular weight (Mw) of less than 10,000 daltons, 2-acryloyloxypropyl phthalate (V2100), 1,2-cyclohexanedicarboxylic acid, mono[1-methyl-2[(1-oxo-2-propenyl)oxy]ethyl] ester (cycloaliphatic V2100), polyalkyl methacrylate (PAMA), alkoxylated tetrahydrofurfuryl (THF) acrylate of the following formula (1), hydroxyethyl acrylate of the following formula (2), phenoxyethylacrylate of the following formula (3), tetrahydrofurfuryl acrylate (THFA or THF acrylate) of the following formula (4), and urethane acrylates having a molecular weight (Mw) of less than 2000 daltons, 
       
         
           
           
               
               
           
         
       
     
     
       8. The cure in place liquid of  claim 1  further comprising at least one structural diluent, wherein the structural diluent is selected from the group consisting of 3,4-epoxycyclohexyl methyl-3,4-epoxycyclohexanecarboxylate (S-21), Bis[(3,4-epoxycyclohexyl)methyl]adipate (S-28), difunctional bisphenol A/epichlorohydrin derived liquid epoxy resin (Epon 828), Bisphenol A epoxy resin having a weight per epoxide of 235-263 g/eq as measured by ASTM D1652 (Epon 834), beta-(3,4-epoxycyclohexyl)ethyltrimethoxysilane (A-186), gamma-glycidoxypropyltrimethoxysilane (A-187), glycidyl ester of neodecanoic acid (EP40), isocyanate-functional urethane acrylate (Desmolux D100), isocyanate-bearing urethane acrylate (Desmolux D200), aliphatic polyisocyanate (low-viscosity hexamethylene diisocyanate (HDI) biuret) (Desmodur N3200), aliphatic polyisocyanate (hexamethylene diisocyanate (HDI) biuret) (Desmodur N100), aliphatic polyisocyanate (hexamethylene diisocyanate (HDI) trimer) (Desmodur N3300), poly(propylene oxide) (PPO) oligomer having a molecular weight (Mw) of less than 5,000 daltons, trimethylolpropane oxetane (TMPO), poly(ethylene oxide) (PEO) oligomer having a molecular weight (Mw) of less than 5,000 daltons, ethyl hexyl oxetane (2EH oxetane), difunctional oxetane, trimethylolpropane triacrylate (TM PTA) of the following formula (5), tripropyleneglycol diacrylate (TPGDA) of the following formula (6), ethoxylated bisphenol A diacrylate of the following formula (7) in which n+m=3, ethoxylated trimethylolpropane triacrylate of the following formula (8), bisphenol A diglycidyl ether diacrylate of the following formula (9), 1,2-cyclic ethers, 1,3-cyclic ethers, 1,4-cyclic ethers, anhydrides, lactones, lactams, cyclic ethers, siloxanes, oxazolines, oxalidines, and bismaleimides; 
       
         
           
           
               
               
           
         
       
     
     
       9. The cure in place liquid composition of  claim 1  wherein the bodying component is selected from the group consisting of polyolefins, polyvinyl aromatics, polyurethanes, polycarbonates, polyethers, and combinations thereof.